What Analysts Think of AMD Stock Ahead of Earnings

Advanced Micro Devices (AMD) is scheduled to report second-quarter earnings with analysts expecting revenue to rise 27% year-over-year to $7.43 billion, primarily driven by strong data center sales. However, adjusted net income is projected to fall to $796.6 million, impacted by an $800 million hit from tighter chip export restrictions to China. Despite the profit headwinds, AMD's stock has gained over 45% year-to-date, fueled by recent suggestions that export curbs could ease and the company's plans to restart MI308 chip exports to China, leading several analysts, including UBS and Bank of America, to raise their price targets and maintain a bullish outlook.

Analysis

Advanced Micro Devices is approaching its second-quarter earnings report with a clear dichotomy between expected performance and market sentiment. Analyst consensus points to robust top-line growth, with revenue projected to increase 27% year-over-year to $7.43 billion, fueled by strong data center demand. However, this is starkly contrasted by an anticipated decline in adjusted net income to $796.6 million from $1.26 billion in the prior-year period, a direct consequence of an $800 million impact from U.S. chip export restrictions to China. Despite this significant headwind on profitability, investor sentiment remains strongly positive, evidenced by a more than 45% year-to-date gain in the stock price. This optimism is primarily driven by recent reports suggesting these export restrictions may soon ease, with AMD planning to restart shipments of its MI308 chips to China upon regulatory approval. This forward-looking narrative is buttressed by bullish analyst actions, including price target increases from UBS to $210 and Bank of America to $200, and a long-term forecast of AMD potentially capturing over 30% of the CPU market by 2026.

Key Decisions for Investors

• Investors should focus less on the headline Q2 profit figures, which are already impacted by known export controls, and more on management's commentary regarding the timeline and certainty of receiving U.S. approval to resume MI308 chip sales to China.
• Given the stock's 45% rally year-to-date, AMD's valuation appears heavily priced for a positive outcome on the export situation, creating significant downside risk if management provides a cautious outlook or signals delays in regulatory approval.
• Long-term investors should monitor for updates on data center sales momentum and any commentary supporting the thesis of continued market share gains against competitors like Intel, which underpins the bull case for reaching a 30% CPU market share by 2026.